T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EV
1501
DELISTED
Eaton Vance Corp.
EV
| $3.44M | ﹤0.01% |
84,166
-5,300
| -6% | -$208K |
|
1502
Genpact
G
$5.78B
| $3.43M | ﹤0.01% |
181,300
| – | – |
|
1503
Liberty Media Series C
FWONK
$26B
| $3.42M | ﹤0.01% |
138,089
-49,334
| -26% | -$1.21M |
|
1504
Signet Jewelers
SIG
$3.6B
| $3.42M | ﹤0.01% |
26,000
| – | – |
|
1505
SiriusXM
SIRI
$9.43B
| $3.41M | ﹤0.01% |
97,426
+11,122
| +13% | +$383K |
|
1506
Phibro Animal Health
PAHC
$1.38B
| $3.4M | ﹤0.01% |
+107,700
| New | +$2.98M |
|
|
PZN
1507
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $3.39M | ﹤0.01% |
357,900
-8,390
| -2% | -$79.2K |
|
|
BKYF
1508
DELISTED
BK KY FINL CORP
BKYF
| $3.35M | ﹤0.01% |
69,300
-459,864
| -87% | -$21.5M |
|
1509
Expro Ltd
XPRO
$2.1B
| $3.33M | ﹤0.01% |
33,333
| – | – |
|
|
TTSH
1510
DELISTED
Tile Shop Holdings
TTSH
| $3.28M | ﹤0.01% |
368,990
+3,800
| +1% | +$33.8K |
|
1511
Realty Income
O
$59.6B
| $3.23M | ﹤0.01% |
69,780
-1,114
| -2% | -$49.4K |
|
1512
Banco Bradesco
BBD
$34.3B
| $3.22M | ﹤0.01% |
614,680
-5,217
| -0.8% | -$29.2K |
|
|
WFT
1513
DELISTED
Weatherford International plc
WFT
| $3.19M | ﹤0.01% |
279,025
+8,610
| +3% | +$129K |
|
|
CCRN
1514
DELISTED
Cross Country Healthcare
CCRN
| $3.17M | ﹤0.01% |
254,300
-50,000
| -16% | -$511K |
|
1515
Sociedad Química y Minera de Chile
SQM
$20.6B
| $3.16M | ﹤0.01% |
136,026
+10,167
| +8% | +$238K |
|
1516
Universal Technical Institute
UTI
$1.42B
| $3.11M | ﹤0.01% |
+315,600
| New | +$3.32M |
|
|
HGG
1517
DELISTED
hhgregg Inc.
HGG
| $3.06M | ﹤0.01% |
404,250
+3,800
| +0.9% | +$24.4K |
|
|
DNY
1518
DELISTED
DONNELLEY R R & SONS CO
DNY
| $3.05M | ﹤0.01% |
181,655
-123,040
| -40% | -$2.07M |
|
|
ESSX
1519
DELISTED
ESSEX RENTAL CORP. COMMON STOCK
ESSX
| $3.05M | ﹤0.01% |
2,310,784
+5,700
| +0.2% | +$8K |
|
1520
American Water Works
AWK
$27.1B
| $3.03M | ﹤0.01% |
56,900
-3,700
| -6% | -$192K |
|
1521
Cedar Fair
FUN
$1.71B
| $2.97M | ﹤0.01% |
62,154
| – | – |
|
|
ATVI
1522
DELISTED
Activision Blizzard
ATVI
| $2.86M | ﹤0.01% |
142,059
-14,294
| -9% | -$288K |
|
|
GXP
1523
DELISTED
Great Plains Energy Incorporated
GXP
| $2.86M | ﹤0.01% |
100,598
-9,600
| -9% | -$253K |
|
1524
3D Systems Corp
DDD
$601M
| $2.8M | ﹤0.01% |
85,125
-1,000
| -1% | -$36.1K |
|
1525
UDR
UDR
$12.2B
| $2.7M | ﹤0.01% |
87,682
-2,300
| -3% | -$68.9K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.